Richard G Vincent - Net Worth and Insider Trading
Richard G Vincent Net Worth
The estimated net worth of Richard G Vincent is at least $66,104 dollars as of 2024-06-21. Richard G Vincent is the CFO of Oncternal Therapeutics Inc and owns about 8,161 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $66,104. Details can be seen in Richard G Vincent's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard G Vincent has not made any transactions after 2023-04-13 and currently still holds the listed stock(s).
Transaction Summary of Richard G Vincent
Richard G Vincent Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard G Vincent owns 2 companies in total, including Oncternal Therapeutics Inc (ONCT) , and Sorrento Therapeutics Inc (SRNE) .
Click here to see the complete history of Richard G Vincent’s form 4 insider trades.
Insider Ownership Summary of Richard G Vincent
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-04-13 | Chief Financial Officer |
| SRNE | Sorrento Therapeutics Inc | 2010-02-05 | Chief Financial Officer |
Richard G Vincent Latest Holdings Summary
Richard G Vincent currently owns a total of 1 stock. Richard G Vincent owns 8,161 shares of Oncternal Therapeutics Inc (ONCT) as of April 13, 2023, with a value of $66,104.
Latest Holdings of Richard G Vincent
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-04-13 | 8,161 | 8.10 | 66,104 |
Holding Weightings of Richard G Vincent
Richard G Vincent Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard G Vincent has made a total of 3 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 1,500 shares on April 13, 2023, which cost Richard G Vincent around $9,000.
Insider Trading History of Richard G Vincent
- 1
Richard G Vincent Trading Performance
GuruFocus tracks the stock performance after each of Richard G Vincent's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard G Vincent is 2.18%. GuruFocus also compares Richard G Vincent's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard G Vincent within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard G Vincent's insider trading performs compared to the benchmark.
Performance of Richard G Vincent
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.1 | | | | | |
| Relative Return to S&P 500(%) | -6.39 | | | | | |
Richard G Vincent Ownership Network
Richard G Vincent Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Richard G Vincent is the Chief Financial Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Richard G Vincent made 1 insider transaction in Oncternal Therapeutics Inc (ONCT) with a net purchase of 30,000. Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 28,000 shares made by Gunnar F. Kaufmann .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Richard G Vincent Mailing Address
Above is the net worth, insider trading, and ownership report for Richard G Vincent. You might contact Richard G Vincent via mailing address: C/o Women First Health Care, 5355 Mira Sorrento Place Ste. 700, San Diego Ca 92121-3825.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
